Liver embolizations in oncology: A review - Part I. Arterial (chemo)embolizations

Medical Oncology

Volumn 25, Issue 1, 2008, Pages 1-11

  Gunvén, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Arterial embolization; Chemoembolization; Cytostatics; Ischemia; Liver neoplasms; Liver surgery; Liver transplantation; Neuroendocrine tumors; Therapeutic embolization

Indexed keywords

ANTHRACYCLINE; CISPLATIN; CORTISONE; DOXORUBICIN; ETHIODIZED OIL; FLUORODEOXYGLUCOSE; FLUOROURACIL; IODINATED POPPYSEED OIL; MITOMYCIN C; OCTREOTIDE;

ARTICLE; ARTIFICIAL EMBOLISM; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; HEMANGIOMA; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRCULATION; LIVER TRANSPLANTATION; METASTASIS; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR BLEEDING; TUMOR GROWTH; TUMOR VOLUME; HEPATIC ARTERY; LIVER; LIVER TUMOR; METHODOLOGY; REVIEW; VASCULARIZATION;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; EMBOLIZATION, THERAPEUTIC; HEPATIC ARTERY; HUMANS; IODIZED OIL; LIVER; LIVER NEOPLASMS;

EID: 42949158412     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-007-0039-3     Document Type: Article

References (125)

1. S Wallace 1990 Hepatic artery infusion and chemoembolization in the management of liver metastases Cardiovasc Intervent Radiol 13 153 60
2. J Belghiti 1999 Continuous versus intermittent portal triad clamping for liver resection: a controlled study Ann Surg 229 369 75
3. JR Hiatt J Gabbay RW Busuttil 1994 Surgical anatomy of the hepatic arteries in 1000 cases Ann Surg 220 50 2
4. H Ngan WC Peh 1997 Arteriovenous shunting in hepatocellular carcinoma: its prevalence and clinical significance Clin Radiol 52 36 40
5. RH Walser 1996 Diagnostic angioscintigraphic evaluation of malignant hepatic tumors before catheter embolization: determination of shunt, flow distribution, and reflux Cardiovasc Intervent Radiol 19 77 81
6. JW Chung JH Park JG Im JK Han MC Han 1993 Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma Radiology 187 689 93
7. I Sakamoto 1998 Complications associated with transcatheter arterial embolization for hepatic tumors Radiographics 18 605 19
8. KM Yoo BG Yoo KS Kim SU Lee BH Han 2004 Cerebral lipiodol embolism during transcatheter arterial chemoembolization Neurology 63 181 3
9. MS Huang 2004 Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma World J Gastroenterol 10 825 9
10. Y Shimamura P Gunven M Ishii K Abe 1993 Temporary redistribution of hepatic or pancreatic blood flow by vascular occluders during intra-arterial chemotherapy for carcinoma of the liver or pancreas Surg Gynecol Obstet 177 617 9
11. J Gates GG Hartnell KE Stuart ME Clouse 1999 Chemoembolization of hepatic neoplasms: safety, complications, and when to worry Radiographics 19 399 414
12. DB Brown 2006 Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy J Vasc Interv Radiol 17 2 Pt 1 225 32
13. Y Shimamura 1988 Combined peripheral and central chemoembolization of liver tumors. Experience with lipiodol-doxorubicin and gelatin sponge (L-TAE) Cancer 61 238 42
14. E De Maio 2003 Transcatheter arterial procedures in the treatment of patients with hepatocellular carcinoma: a review of literature Crit Rev Oncol Hematol 46 285 95
15. JM Llovet 2002 (Barcelona Liver Cancer Group). Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 9319 1734 39
16. G Pelletier 1998 Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial Groupe CHCJ Hepatol 29 129 34
17. CM Lo 2002 Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164 71
18. MV Madden 1993 Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma Gut 34 1598 600
19. J Bruix 1998 Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution Hepatology 27 1578 83
20. MY Latoo A Oliver D Roebuck 2002 Anaesthetic management of hepatic artery chemoembolization in a paediatric patient Paediatr Anaesth 12 629 31
21. JW Park 2005 Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: report of a prospective study Am J Gastroenterol 100 2194 200
22. JW Jang 2006 A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization Hepatology Feb;43 2 233 40
23. MS Chen 2002 High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma World J Gastroenterol 8 74 8
24. HY Cheng 2004 Adjustment of lipiodol dose according to tumor blood supply during transcatheter arterial chemoembolization for large hepatocellular carcinoma by multidetector helical CT World J Gastroenterol 10 2753 55
25. JL Raoul 1992 Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin Cancer 70 585 90
26. JM Llovet J Bruix 2003 Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 47 479 47
27. C Camma 2002 Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 47 54
28. W Lu Y Li X He Y Chen 2003 Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors Hepatogastroenterology 50 2079 83
29. A Castells 1995 Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever J Hepatol 22 460 5
30. M Kaibori 2004 Preoperative chemolipiodolization of the whole liver for hepatocellular carcinoma Anticancer Res 24 3b 1929 33
31. Y Hatanaka 1995 Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management Radiology 195 747 52
32. CD Lu YG Qi SY Peng 1994 Lipiodolization with or without gelatin sponge in hepatic arterial chemoembolization for hepatocellular carcinoma Chin Med J (Engl) 107 209 15
33. SJ Wigmore 2003 Postchemoembolisation syndrome-tumour necrosis or hepatocyte injury? Br J Cancer 89 1473 77
34. SY Song 2001 Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome J Vasc Interv Radiol 12 313 320
35. X-ray contrast media. Pharmacology, clinic. (Review in Swedish.) The Swedish Board of Health and Welfare, Drug Information 1976;3:1 p. 53-9 (Socialstyrelsens läkemedelsinformation. Röntgenkontrastmedel. Farmakologi, klinik. 1976 3:1, p. 53-59).
36. H Nakamura 1992 Outcome of localized hepatocellular carcinoma treated with segmental arterioportal chemoembolization Cancer Chemother Pharmacol 31 Suppl S69 S71
37. TI Huo JC Wu PC Lee FY Chang SD Lee 2004 Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study Liver Int 24 210 5
38. DB Brown 2006 Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies J Vasc Interv Radiol 17 2 Pt 1 217 23
39. M Ryu 1997 Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study Jpn J Clin Oncol 27 251 7
40. K Takayasu 2000 Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma AJR Am J Roentgenol 175 699 704
41. S Yamasaki 1996 A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma Jpn J Cancer Res 87 206 11
42. JD Schwartz M Schwartz J Mandeli M Sung 2002 Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials Lancet Oncol 3 593 603
43. Chan ES, Chow PK, Tai B, Machin D, Soo K. Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma. Cochrane Database Syst Rev 2000;(2):CD001199.
44. CC Wu 1995 Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal Br J Surg 82 122 6
45. S Bhattacharya 1997 Small hepatocellular carcinomas in cirrhotic explant livers: identification by macroscopic examination and lipiodol localization Hepatology 25 613 8
46. PC Kwok 2003 Randomized controlled trial to compare the dose of adjuvant chemotherapy after curative resection of hepatocellular carcinoma J Gastroenterol Hepatol 18 450 5
47. Y Shimamura P Gunven M Ishii M Ono K Abe 1993 Debulking surgery and arterial embolization for unresectable liver cancer Hepatogastroenterology 40 10 3
48. K Inoue 2004 Volume reduction surgery for advanced hepatocellular carcinoma J Cancer Res Clin Oncol 130 362 6 Epub 2004 Mar 18
49. H Wakabayashi 2003 Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions J Surg Oncol 82 98 103
50. K Takayasu 1989 Clinical and radiologic assessments of the results of hepatectomy for small hepatocellular carcinoma and therapeutic arterial embolization for postoperative recurrence Cancer 64 1848 52
51. M Okazaki 1993 Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy Hepatogastroenterology 40 320 3
52. C Bartolozzi 1995 Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization Radiology 197 812 8
53. M Koda 2001 Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study Cancer 92 1516 24
54. K Kamada 2002 Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma Am J Surg 184 284 90
55. K Dohmen 2001 Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate Hepatogastroenterology 48 1409 65
56. K Tanaka 1998 The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis Cancer 82 78 85
57. R Lencioni 1998 Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate Eur Radiol 8 439 44
58. M Akamatsu 2004 Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial Liver Int 24 625 9
59. L Marelli 2006 Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies Cancer Treat Rev 32 594 606
60. YP Yeung 2005 Natural history of untreated nonsurgical hepatocellular carcinoma Am J Gastroenterol 100 1995 2004
61. K Arai 1990 Efficacy of transcatheter arterial embolization therapy for small hepatocellular carcinomas: comparison with other treatments Radiat Med 8 191 8
62. MK Jang 2004 Role of additional angiography and chemoembolization in patients with hepatocellular carcinoma who achieved complete necrosis following transarterial chemoembolization J Gastroenterol Hepatol 19 1074 80
63. DB Brown 2004 Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma J Vasc Interv Radiol 15 1209 18
64. CB O'Suilleabhain 2003 Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma Br J Surg 90 325 31
65. G Pelletier 1990 A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma J Hepatol 11 181 4
66. DY Lin YF Liaw TY Lee CM Lai 1988 Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma -a randomized controlled trial Gastroenterology ;94 453 6
67. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire 1995 A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma N Engl J Med 332 1256 61
68. JF Geschwind DE Ramsey MA Choti PJ Thuluvath MS Huncharek 2003 Chemoembolization of hepatocellular carcinoma: results of a metaanalysis Am J Clin Oncol 26 344 9
69. DL Reidy JD Schwartz 2004 Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials - I: hepatic arterial embolization and embolization-based therapies in unresectable hepatocellular carcinoma Anticancer Drugs 15 427 37
70. M Staunton JD Dodd PA McCormick DE Malone 2005 Finding evidence-based answers to practical questions in radiology: which patients with inoperable hepatocellular carcinoma will survive longer after transarterial chemoembolization? Radiology 237 404 13
71. JM Llovet M Sala 2005 Non-surgical therapies of hepatocellular carcinoma Eur J Gastroenterol Hepatol 17 505 13
72. HS Lee 2002 Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study J Clin Oncol 20 4459 65
73. KT Mok 2003 Multimodality management of hepatocellular carcinoma larger than 10 cm J Am Coll Surg 197 730 8
74. MS Liem RT Poon CM Lo WK Tso ST Fan 2005 Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation World J Gastroenterol 11 4465 71
75. WJ Wall PJ Marotta 2000 Surgery and transplantation for hepatocellular cancer Liver Transpl 6 6 Suppl 2 S16 22
76. T Decaens 2005 Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma Liver Transpl 11 767 75
77. RA Fisher 2004 Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list Clin Transplant 18 502 12
78. S Herber 2005 TACE: therapy of the HCC before liver transplantation- experiences (in German) Rofo 177 681 90
79. YF Cheng 2005 Impact of pre-operative transarterial embolization on the treatment of hepatocellular carcinoma with liver transplantation World J Gastroenterol 11 1433 38
80. A Roche 2003 Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors Eur Radiol 13 136 40 Epub 2002 Jul 23
81. C Zimmer P Kienbaum R Wiesemes J Peters 2003 Somatostatin does not prevent serotonin release and flushing during chemoembolization of carcinoid liver metastases Anesthesiology 98 1007 11
82. H Ahlman O Nilsson M Olausson 2004 Interventional treatment of the carcinoid syndrome Neuroendocrinology 80 Suppl 1 67 73
83. S Gupta 2005 Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival Cancer 104 1590 1602
84. AP Venook 1999 Embolization and chemoembolization therapy for neuroendocrine tumors Curr Opin Oncol 11 38 41
85. D O'Toole P Ruszniewski 2005 Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours Best Pract Res Clin Gastroenterol 19 585 94
86. M Kulke 2005 Advances in the treatment of neuroendocrine tumors Curr Treat Options Oncol 6 397 409
87. JG Touzios 2005 Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg 241 776 83
88. V Meij 2005 Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation World J Surg Oncol 3 75
89. CG Moertel 1994 The management of patients with advanced carcinoid tumors and islet cell carcinomas Ann Intern Med 120 302 9
90. B Hirshberg 2005 Malignant insulinoma: spectrum of unusual clinical features Cancer 104 264 72
91. M Nesovic J Ciric S Radojkovic M Zarkovic M Durovic 1992 Improvement of metastatic endocrine tumors of the pancreas by hepatic artery chemoembolization J Endocrinol Invest 15 543 7
92. A Starke 2005 Malignant metastatic insulinoma-postoperative treatment and follow-up World J Surg 29 789 93
93. A Scott D Hinwood R Donnelly 2002 Radio-frequency ablation for symptom control in a patient with metastatic pancreatic insulinoma Clin Endocrinol 56 557 9
94. M Civera Andres JT Real Collado I Martinez Uso FJ Ampudia Blasco R Carmena Rodriguez 2000 Selective therapeutic embolization in malignant insulinoma (in Spanish) Rev Clin Esp 200 548 50
95. T Sato 2000 Strategy for pancreatic endocrine tumors Hepatogastroenterology 47 537 9
96. A Roche 2004 Prognostic factors for chemoembolization in liver metastasis from endocrine tumors Hepatogastroenterology 51 1751 6
97. R Brentjens L Saltz 2001 Islet cell tumors of the pancreas: the medical oncologist's perspective Surg Clin North Am 81 527 42
98. Neuroendocrine tumors. National Comprehensive Cancer Network: Clinical practice guidelines in oncology version 2.2005. hhtp://www.nccn.org/ professionals/physician-gls/PDF/neuroendocrine.pdf
99. K Azimuddin RS Chamberlain 2001 The surgical management of pancreatic neuroendocrine tumors Surg Clin North Am 81 511 25
100. U Plöckinger 2004 European Neuroendocrine Tumour Society. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS) Neuroendocrinology 80 394 424 Epub 2005 Apr 18
101. R Hage AB de la Riviere CA Seldenrijk JM van den Bosch 2003 Update in pulmonary carcinoid tumors: a review article Ann Surg Oncol 10 697 704
102. RS Chamberlain 2000 Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 190 432 45
103. K Lorenz 2005 Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma Surgery 138 986 93
104. Y Ohtsuka 2004 Optimal strategy of preoperative transcatheter arterial chemoembolization for hepatoblastoma Surg Today 34 127 33
105. S Warmann 2003 Interventional treatment of infantile hepatic hemangioendothelioma J Pediatr Surg 38 1177 81
106. MH Malogolowkin P Stanley DA Steele JA Ortega 2000 Feasibility and toxicity of chemoembolization for children with liver tumors J Clin Oncol 18 1279 84
107. CM Arcement 2000 Intrahepatic chemoembolization in unresectable pediatric liver malignancies Pediatr Radiol 30 779 85
108. SC Lee JW Chung KH Kim WK Kim 1999 Successful transumbilical embolization of congenitally ruptured hepatoblastoma J Pediatr Surg 34 1851 52
109. M Weintraub 2004 Successful treatment of progressive stage 4s hepatic neuroblastoma in a neonate with intra-arterial chemoembolization Pediatr Blood Cancer 43 148 51
110. Y Yokoi 2003 Aggressive hepatectomy for complete remission of metastatic germ cell tumor following chemotherapy: report of a case Hepatogastroenterology 50 1136 9
111. SD St Peter AA Moss EA Huettl KO Leslie DC Mulligan 2003 Chemoembolization followed by orthotopic liver transplant for epithelioid hemangioendothelioma Clin Transplant 17 549 53
112. EK Lang CL Brown Jr 1993 Colorectal metastases to the liver: selective chemoembolization Radiology 189 417 22
113. DJ Martinelli 1994 Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma Cancer 74 1706 12
114. HS Salman 2002 Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver Clin Colorectal Cancer 2 173 9
115. M Kameyama 1993 Delayed washout of intratumor blood flow is associated with good response to intraarterial chemoembolization for liver metastasis of colorectal cancer Surgery 114 97 101
116. TM Hunt 1990 Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases Br J Surg 77 779 82
117. I Burger 2005 Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution J Vasc Interv Radiol 16 353 61
118. DK Rajan 2001 Sarcomas metastatic to the liver: response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization J Vasc Interv Radiol 12 187 93
119. K Kobayashi 2006 Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factors Cancer 107 2833 41
120. ED Feldman JF Pingpank HR Alexander Jr 2004 Regional treatment options for patients with ocular melanoma metastatic to the liver Ann Surg Oncol 11 290 97
121. AY Bedikian 1995 Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors Cancer 76 1665 70
122. SS Agarwala R Panikkar JM Kirkwood 2004 Phase I/II randomized trial of intrahepatic arterial infusion chemotherapy with cisplatin and chemoembolization with cisplatin and polyvinyl sponge in patients with ocular melanoma metastatic to the liver Melanoma Res 14 217 22
123. MF Giroux RA Baum MC Soulen 2004 Chemoembolization of liver metastasis from breast carcinoma J Vasc Interv Radiol 15 289 91
124. XP Li ZQ Meng WJ Guo J Li 2005 Treatment for liver metastases from breast cancer: results and prognostic factors World J Gastroenterol 11 3782 7
125. L Braga 2004 Does hypervascularity of liver metastases as detected on MRI predict disease progression in breast cancer patients? AJR Am J Roentgenol 182 1207 13